Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)

NCT04391959 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Meibomian Gland Dysfunction

Interventions

DRUG: AZR-MD-001 Active
DRUG: AZR-MD-001 Vehicle

Sponsor

Azura Ophthalmics

Collaborators

[object Object]